Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China
PRNewsWire
·
2026-05-22
·
via The Tech Buzz - Press Releases
Results provide important clinical evidence to support ApolloBio's future regulatory submission in China of V…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。